VivoSim Labs, INC.

VIVS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
298
SEC Filings

Business Summary

PART I Item 1. Bu siness. Overview VivoSim Labs, Inc., formerly known as Organovo Holdings, Inc. ("VivoSim," we, us, our, the Company and our Company), is a pharmaceutical and biotechnology services company that is focused on providing testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. We offer partners liver and intestinal toxicology insights using our new approach methodologies ("NAM") models. We anticipate accelerated adoption of human t...

Next Earnings

Q2 FY2026 — expected 2026-08-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVIVSdiscussed_in_filing Cybersecurity
topic_mentionVIVSdiscussed_in_filing Cybersecurity
topic_mentionVIVSdiscussed_in_filing Healthcare & Bio
topic_mentionVIVSdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-06-052025-03-310000950170-25-082312EDGAR50K words
2024-05-312024-03-310000950170-24-067301EDGAR—
2023-07-142023-03-310000950170-23-032889EDGAR—
2022-06-102022-03-310001564590-22-022994EDGAR—
2021-06-152021-03-310001564590-21-032980EDGAR—
2020-05-282020-03-310001564590-20-027310EDGAR—
2019-06-032019-03-310001564590-19-021444EDGAR—
2018-05-312018-03-310001564590-18-014814EDGAR—
2017-06-072017-03-310001564590-17-012240EDGAR—
2016-06-092016-03-310001564590-16-020442EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310001193125-26-046520EDGAR40K words
2025-11-062025-09-300001193125-25-269483EDGAR—
2025-08-122025-06-300000950170-25-107284EDGAR—
2025-02-192024-12-310000950170-25-022778EDGAR—
2024-11-082024-09-300000950170-24-124044EDGAR—
2024-08-052024-06-300000950170-24-090726EDGAR—
2024-02-082023-12-310000950170-24-012754EDGAR—
2023-11-092023-09-300000950170-23-062228EDGAR—
2023-08-102023-06-300000950170-23-041307EDGAR—
2023-02-092022-12-310000950170-23-002327EDGAR—
2022-11-102022-09-300001564590-22-037381EDGAR—
2022-08-112022-06-300001564590-22-029133EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-030001193125-26-142106EDGAR3K words
2025-12-180001193125-25-324794EDGAR—
2025-08-140000950170-25-108447EDGAR—
2025-05-060000950170-25-063979EDGAR—
2025-04-240000950170-25-057685EDGAR—
2025-04-230000950170-25-056974EDGAR—
2025-04-020000950170-25-048888EDGAR—
2025-03-270000950170-25-045740EDGAR—
2025-03-260000950170-25-044801EDGAR—
2025-03-210000950170-25-042903EDGAR—

298 total filings indexed. 266 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001497253
TickerVIVS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8b57d52dfe957863d4731c980715ecbd245c1e73949c89e7a88a5e8bee338da4
parent: 1b9b7aeff8221ed3c7b8901b60a6a06df2215d17599ecc44cccda545445fe841
content hash: f60d7c2495cfd3304a4879b049ea1c11e4bbedd6311ee4aa4d8f8c0641190b79
signed: 2026-04-13T04:48:06.094Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf